{"title":"[Establishment and Evaluation of a Nucleic Acid Amplification Test for Spectinomycin-Resistant <i>Neisseria gonorrhoeae</i>].","authors":"Guiqin Yang, Menghuan Li, Youwei Wang, Gang Yong, Hongren Wang, Mingjiang Bie","doi":"10.12182/20250160402","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To develop and evaluate a nucleic acid amplification test for spectinomycin-resistant <i>Neisseria gonorrhoeae</i> (<i>N. gonorrhoeae</i>).</p><p><strong>Methods: </strong><i>N. gonorrhoeae</i>-specific primers NG1/NG2 and primers specific to the N. gonorrhoeae <i>rpsE</i> gene mutation (80_82 delTTA) were designed. Genomic nucleic acids of spectinomycin-sensitive and resistant <i>N. gonorrhoeae</i>, <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, and <i>Salmonella typhi</i> were used as templates to be amplified by PCR and quantitative real-time PCR (qPCR). The sensitivity and specificity of the method were evaluated accordingly.</p><p><strong>Results: </strong>The NG1/NG2 primers could effectively amplify specific fragments of <i>N. gonorrhoeae</i>, yielding negative results for the nucleic acid amplification test of the other types of bacteria tested. E64/E175R and E-87/E95R could effectively differentiate the wild type and mutant (80_82 delTTA) <i>rpsE</i> genes. In PCR reactions, the minimum limits of NG1/NG2, E64/E175R, and E87/E95R for the target genes were 414.8 copies, 414.8 copies, and 4.1 copies /μL, respectively, while those for qPCR reactions were 41.5, 41.5, and 4.1×10<sup>-2</sup> copies /μL, respectively.</p><p><strong>Conclusion: </strong>A nucleic acid amplification test for spectinomycin-resistant <i>N. gonorrhoeae</i> with high specificity and sensitivity was successfully established in this study, which is expected to provide support for the rapid diagnosis of <i>N. gonorrhoeae</i> infection and treatment decision-making in clinical settings.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 1","pages":"262-267"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11914003/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"四川大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12182/20250160402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To develop and evaluate a nucleic acid amplification test for spectinomycin-resistant Neisseria gonorrhoeae (N. gonorrhoeae).
Methods: N. gonorrhoeae-specific primers NG1/NG2 and primers specific to the N. gonorrhoeae rpsE gene mutation (80_82 delTTA) were designed. Genomic nucleic acids of spectinomycin-sensitive and resistant N. gonorrhoeae, Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhi were used as templates to be amplified by PCR and quantitative real-time PCR (qPCR). The sensitivity and specificity of the method were evaluated accordingly.
Results: The NG1/NG2 primers could effectively amplify specific fragments of N. gonorrhoeae, yielding negative results for the nucleic acid amplification test of the other types of bacteria tested. E64/E175R and E-87/E95R could effectively differentiate the wild type and mutant (80_82 delTTA) rpsE genes. In PCR reactions, the minimum limits of NG1/NG2, E64/E175R, and E87/E95R for the target genes were 414.8 copies, 414.8 copies, and 4.1 copies /μL, respectively, while those for qPCR reactions were 41.5, 41.5, and 4.1×10-2 copies /μL, respectively.
Conclusion: A nucleic acid amplification test for spectinomycin-resistant N. gonorrhoeae with high specificity and sensitivity was successfully established in this study, which is expected to provide support for the rapid diagnosis of N. gonorrhoeae infection and treatment decision-making in clinical settings.
四川大学学报(医学版)Biochemistry, Genetics and Molecular Biology-Molecular Biology
CiteScore
0.70
自引率
0.00%
发文量
8695
期刊介绍:
"Journal of Sichuan University (Medical Edition)" is a comprehensive medical academic journal sponsored by Sichuan University, a higher education institution directly under the Ministry of Education of the People's Republic of China. It was founded in 1959 and was originally named "Journal of Sichuan Medical College". In 1986, it was renamed "Journal of West China University of Medical Sciences". In 2003, it was renamed "Journal of Sichuan University (Medical Edition)" (bimonthly).
"Journal of Sichuan University (Medical Edition)" is a Chinese core journal and a Chinese authoritative academic journal (RCCSE). It is included in the retrieval systems such as China Science and Technology Papers and Citation Database (CSTPCD), China Science Citation Database (CSCD) (core version), Peking University Library's "Overview of Chinese Core Journals", the U.S. "Index Medica" (IM/Medline), the U.S. "PubMed Central" (PMC), the U.S. "Biological Abstracts" (BA), the U.S. "Chemical Abstracts" (CA), the U.S. EBSCO, the Netherlands "Abstracts and Citation Database" (Scopus), the Japan Science and Technology Agency Database (JST), the Russian "Abstract Magazine", the Chinese Biomedical Literature CD-ROM Database (CBMdisc), the Chinese Biomedical Periodical Literature Database (CMCC), the China Academic Journal Network Full-text Database (CNKI), the Chinese Academic Journal (CD-ROM Edition), and the Wanfang Data-Digital Journal Group.